ロード中...
Second malignancies after multiple myeloma: from 1960s to 2010s
Based on small numbers, recent reports from 3 randomized trials have consistently demonstrated more hematologic malignancies in patients treated with lenalidomide as maintenance (vs placebo). This fact has prompted concern and highlighted the association between multiple myeloma and second malignanc...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3327452/ https://ncbi.nlm.nih.gov/pubmed/22310913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-12-381426 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|